Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathies,Age-related”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04018482
What this trial is testing

Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study)

Who this might be right for
Age-related Macular DegenerationDiabetic RetinopathyDiabetic Macular Edema
California Retina Consultants 50
Large-scale testing (Phase 3)Study completedNCT00531024
What this trial is testing

Systemic Avastin Therapy in Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 30
Testing effectiveness (Phase 2)Study completedNCT03558061
What this trial is testing

Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration

Who this might be right for
Wet Age-related Macular Degeneration
Alkahest, Inc. 30
Early research (Phase 1)Study completedNCT07484074
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324

Who this might be right for
Diabetic Macular Edema (DME)Neovascular (Wet) Age-Related Macular Degeneration
Ollin Biosciences, Inc. 164
Testing effectiveness (Phase 2)Study completedNCT01632527
What this trial is testing

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular DegenerationMacular DegenerationAMD
StemCells, Inc. 15
Not applicableEnded earlyNCT02779686
What this trial is testing

PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (ARMD)
University of Missouri-Columbia 32
Not applicableStudy completedNCT07420361
What this trial is testing

Lutein Iontophoresis in Intermediate AMD and Reticular Pseudodrusen - a Retrospective Study

Who this might be right for
Intermediate Age-Related Macular Degeneration With Reticular Pseudodrusen
Mario Damiano Toro 30
Not applicableStudy completedNCT06174181
What this trial is testing

Preventive TREatment of Dry Eye in Patients Receiving Repeated Intravitreal Injections for Age-related Macular Degeneration

Who this might be right for
Dry Eye SyndromesAge-Related Macular Degeneration
Direction Centrale du Service de Santé des Armées 42
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Testing effectiveness (Phase 2)Study completedNCT01494805
What this trial is testing

Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related MaculopathiesAge-related Maculopathy+5 more
Lions Eye Institute, Perth, Western Australia 40
Not applicableStudy completedNCT03744806
What this trial is testing

Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Lublin 48
Testing effectiveness (Phase 2)Study completedNCT02314299
What this trial is testing

MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaAge-related Macular Degeneration
Stealth BioTherapeutics Inc. 20
Large-scale testing (Phase 3)Looking for participantsNCT07007065
What this trial is testing

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
AbbVie 561
Not applicableStudy completedNCT00001733
What this trial is testing

Screening for Studies on Retinovascular Diseases

Who this might be right for
Diabetic RetinopathyMacular DegenerationPathologic Neovascularization+1 more
National Eye Institute (NEI) 2,000
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Not applicableStudy completedNCT00692887
What this trial is testing

Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT03216538
What this trial is testing

Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Feramda 20
Post-approval studies (Phase 4)UnknownNCT01961414
What this trial is testing

Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910

Who this might be right for
Exudative Age-related Macular Degeneration
Palmetto Retina Center, LLC 45
Not applicableStudy completedNCT00759044
What this trial is testing

Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function

Who this might be right for
Age-Related MaculopathyDiabetic Macular Edema
Association for Innovation and Biomedical Research on Light and Image 90
Large-scale testing (Phase 3)Looking for participantsNCT06952452
What this trial is testing

Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD)

Who this might be right for
Wet Age-related Macular Degeneration
Parc de Salut Mar 630
Next Page